LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Optical Sensor to Detect Vitamin B12 Deficiency

By LabMedica International staff writers
Posted on 26 Oct 2016
Print article
Image: Dr. Georgios Tsiminis in his photonics laboratory (Photo courtesy of the University of Adelaide).
Image: Dr. Georgios Tsiminis in his photonics laboratory (Photo courtesy of the University of Adelaide).
Researchers have developed the first optical sensor that can detect vitamin B12 in diluted human blood – and a first step towards a low-cost, portable, broadscale B12 deficiency test that would overcome limitations of current methods for monitoring levels in high-risk individuals and populations.

The device, developed by scientists at the University of Adelaide (Adelaide, Australia), was presented October 17, 2016, at the inaugural “SPIE BioPhotonics Australasia” international conference in Adelaide.

“Vitamin B12 deficiency has been shown to be a potential modifiable risk factor for dementia and Alzheimer’s disease and is associated with cognitive decline,” said Dr. Georgios Tsiminis, research fellow at the University of Adelaide, “Older adults are particularly at risk of B12 deficiency due to age-related reduction in absorbing vitamin B12 received through their diet.

Currently at proof-of-concept stage, the sensor demonstrates feasibility of testing for vitamin B12 in human blood serum without the need for a full laboratory test. It could provide point-of-care B12 tracking in, for example, healthy ageing adults, enabling early treatment intervention as soon as deficiency is detected.

“This is the first time a rapid technique based on optical spectroscopy has been shown to be able to detect vitamin B12 in human blood serum. We believe this is a very promising first step towards achieving this goal,” said Dr. Tsiminis.

Currently, routine B12 testing is not being carried out due to time and cost limitations. “Our method provides a realistic basis for a system that is portable, cost-effective, and affords rapid results, along the lines of the pin-prick test for diabetes,” said Dr. Tsiminis. The device uses Raman spectroscopy to produce the vitamin B12 optical fingerprint, takes under 1 minute to measure B12 in human blood, and requires minimal preparation.

Related Links:
University of Adelaide

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more